{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T16:44:36Z","timestamp":1793724276836,"version":"4.6.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2012,11,2]],"date-time":"2012-11-02T00:00:00Z","timestamp":1351814400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1007\/s10549-012-2318-8","type":"journal-article","created":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T01:26:34Z","timestamp":1351733194000},"page":"627-633","source":"Crossref","is-referenced-by-count":119,"title":["The role of chemoprevention in modifying the risk of breast cancer in women with atypical breast lesions"],"prefix":"10.1007","volume":"136","author":[{"given":"Suzanne B.","family":"Coopey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele","family":"Mazzola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julliette M.","family":"Buckley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Sharko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmet K.","family":"Belli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth M. H.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda","family":"Polubriaginof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Parmigiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judy E.","family":"Garber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara L.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele A.","family":"Gadd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle C.","family":"Specht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony J.","family":"Guidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constance A.","family":"Roche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin S.","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,11,2]]},"reference":[{"issue":"3","key":"2318_CR1","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1056\/NEJM198501173120303","volume":"312","author":"WD Dupont","year":"1985","unstructured":"Dupont WD, Page DL (1985) Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med 312(3):146\u2013151","journal-title":"N Engl J Med"},{"issue":"3","key":"2318_CR2","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJMoa044383","volume":"353","author":"LC Hartmann","year":"2005","unstructured":"Hartmann LC, Sellers TA, Frost MH et al (2005) Benign breast disease and the risk of breast cancer. N Engl J Med 353(3):229\u2013237","journal-title":"N Engl J Med"},{"issue":"19","key":"2318_CR3","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1200\/JCO.2006.09.0217","volume":"25","author":"AC Degnim","year":"2007","unstructured":"Degnim AC, Visscher DW, Berman HK et al (2007) Stratification of breast cancer risk in women with atypia: a Mayo Cohort Study. J Clin Oncol 25(19):2671\u20132677","journal-title":"J Clin Oncol"},{"issue":"11","key":"2318_CR4","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1002\/1097-0142(19850601)55:11<2698::AID-CNCR2820551127>3.0.CO;2-A","volume":"55","author":"DL Page","year":"1985","unstructured":"Page DL, Dupont WD, Rogers LW, Rados MS (1985) Atypical hyperplastic lesions of the female breast: a long-term follow-up study. Cancer 55(11):2698\u20132708","journal-title":"Cancer"},{"issue":"2","key":"2318_CR5","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/cncr.22408","volume":"109","author":"LC Collins","year":"2007","unstructured":"Collins LC, Baer HJ, Tamimi RM, Connolly JL, Colditz GA, Schnitt SJ (2007) Magnitude and laterality of breast cancer risk according to histologic type of atypical hyperplasia. Results from the Nurses\u2019 Health Study. Cancer 109(2):180\u2013187","journal-title":"Cancer"},{"key":"2318_CR6","first-page":"297","volume":"6","author":"LM Marshall","year":"1997","unstructured":"Marshall LM, Hunter DJ, Connolly JL, Schnitt SJ, Byrne C, London SJ, Colditz GA (1997) Risk of breast cancer associated with atypical hyperplasia of lobular and ductal types. Cancer Epidemiol Biomarkers Prev 6:297\u2013301","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"7","key":"2318_CR7","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1007\/s00432-011-0979-z","volume":"137","author":"WB Zhou","year":"2011","unstructured":"Zhou WB, Xue DQ, Liu XA, Ding Q, Wang S (2011) The influence of family history and histological stratification on breast cancer risk in women with benign breast disease: a meta-analysis. J Cancer Res Clin Oncol 137(7):1053\u20131060","journal-title":"J Cancer Res Clin Oncol"},{"issue":"3","key":"2318_CR8","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/00000478-197809000-00001","volume":"2","author":"PP Rosen","year":"1978","unstructured":"Rosen PP, Lieberman PH, Braun DW, Kosloff C, Adair F (1978) Lobular carcinoma in situ of the breast. Detailed analysis of 99 patients with average follow-up of 24\u00a0years. Am J Surg Pathol 2(3):225\u2013251","journal-title":"Am J Surg Pathol"},{"key":"2318_CR9","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1002\/1097-0142(197808)42:2<737::AID-CNCR2820420247>3.0.CO;2-T","volume":"42","author":"CD Haagensen","year":"1978","unstructured":"Haagensen CD, Lane N, Lattes R, Bodian C (1978) Lobular neoplasia (so-called lobular carcinoma in situ) of the breast. Cancer 42:737\u2013769","journal-title":"Cancer"},{"issue":"12","key":"2318_CR10","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/0046-8177(91)90105-X","volume":"22","author":"DL Page","year":"1991","unstructured":"Page DL, Kidd TE Jr, Dupont WD, Simpson JF, Rogers LW (1991) Lobular neoplasia of the breast: higher risk for subsequent invasive cancer predicted by more extensive disease. Hum Pathol 22(12):1232\u20131239","journal-title":"Hum Pathol"},{"issue":"1","key":"2318_CR11","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/BF02409052","volume":"3","author":"S Zurrida","year":"1996","unstructured":"Zurrida S, Bartoli C, Galimberti V, Raselli R, Barletta L (1996) Interpretation of the risk associated with the unexpected finding of lobular carcinoma in situ. Ann Surg Oncol 3(1):57\u201361","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"2318_CR12","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1002\/(SICI)1097-0142(19960901)78:5<1024::AID-CNCR12>3.0.CO;2-4","volume":"78","author":"CA Bodian","year":"1996","unstructured":"Bodian CA, Perzin KH, Lattes R (1996) Lobular neoplasia: long term risk of breast cancer and relation to other factors. Cancer 78(5):1024\u20131034","journal-title":"Cancer"},{"issue":"1","key":"2318_CR13","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/00000658-199701000-00008","volume":"225","author":"LA Habel","year":"1997","unstructured":"Habel LA, Moe RE, Daling JR, Holte S, Rossing MA, Weiss NS (1997) Risk of contralateral breast cancer among women with carcinoma in situ of the breast. Ann Surg 225(1):69\u201375","journal-title":"Ann Surg"},{"key":"2318_CR14","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/S0140-6736(99)03703-4","volume":"355","author":"F W\u00e4rnberg","year":"2000","unstructured":"W\u00e4rnberg F, Yuen J, Holmberg L (2000) Risk of subsequent invasive breast cancer after breast carcinoma in situ. Lancet 355:724\u2013725","journal-title":"Lancet"},{"key":"2318_CR15","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1002\/(SICI)1097-0215(19980729)77:3<392::AID-IJC14>3.0.CO;2-A","volume":"77","author":"S Franceschi","year":"1998","unstructured":"Franceschi S, Levi F, LaVecchia C, Randimbison L, Te VC (1998) Second cancers following in situ carcinoma of the breast. Int J Cancer 77:392\u2013395","journal-title":"Int J Cancer"},{"key":"2318_CR16","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1093\/jnci\/90.18.1371","volume":"90","author":"B Fisher","year":"1998","unstructured":"Fisher B, Costantino JP, Wickerham DL et al (1998) Tamoxifen for the prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst 90:1371\u20131388","journal-title":"J Natl Cancer Inst"},{"issue":"23","key":"2318_CR17","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1001\/jama.281.23.2189","volume":"281","author":"SR Cummings","year":"1999","unstructured":"Cummings SR, Eckert S, Krueger KA et al (1999) The effect of raloxifene on risk of breast cancer in postmenopausal women. Results from the MORE randomized trial. JAMA 281(23):2189\u20132197","journal-title":"JAMA"},{"issue":"6","key":"2318_CR18","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1158\/1940-6207.CAPR-10-0076","volume":"3","author":"VG Vogel","year":"2010","unstructured":"Vogel VG, Costantino JP, Wickerham DL et al (2010) Update of the national surgical adjuvant breast and bowel project study of tamoxifen and raloxifene (STAR) P-2 trial: preventing breast cancer. Cancer Prev Res 3(6):696\u2013706","journal-title":"Cancer Prev Res"},{"issue":"25","key":"2318_CR19","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1056\/NEJMoa1103507","volume":"364","author":"PE Goss","year":"2011","unstructured":"Goss PE, Ingle JN, Al\u00e9s-Mart\u00ednez JE et al (2011) Exemestane for breast-cancer prevention in postmenopausal women. N Engl J Med 364(25):2381\u20132391","journal-title":"N Engl J Med"},{"issue":"18","key":"2318_CR20","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.1200\/JCO.2009.27.8077","volume":"28","author":"ME Ropka","year":"2010","unstructured":"Ropka ME, Keim J, Philbrick JT (2010) Patient decisions about breast cancer chemoprevention: a systematic review and meta-analysis. J Clin Oncol 28(18):3090\u20133095","journal-title":"J Clin Oncol"},{"key":"2318_CR21","doi-asserted-by":"crossref","first-page":"23","DOI":"10.4103\/2153-3539.97788","volume":"3","author":"JM Buckley","year":"2012","unstructured":"Buckley JM, Coopey SB, Mazzola E et al (2012) The feasibility of using natural language processing to extract clinical information from 76,000 breast pathology reports. J Pathol Inform 3:23\u201329","journal-title":"J Pathol Inform"},{"key":"2318_CR22","first-page":"137","volume-title":"Diagnostic histopathology of the breast","author":"DL Page","year":"1987","unstructured":"Page DL, Anderson TJ (1987) Diagnostic histopathology of the breast. Churchill Livingstone, Edinburgh, pp 137\u2013184"},{"issue":"1","key":"2318_CR23","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/biomet\/70.1.41","volume":"70","author":"PR Rosenbaum","year":"1983","unstructured":"Rosenbaum PR, Rubin DB (1983) The central role of the propensity score in observational studies for causal effects. Biometrika 70(1):41\u201355","journal-title":"Biometrika"},{"key":"2318_CR24","doi-asserted-by":"crossref","first-page":"757","DOI":"10.7326\/0003-4819-127-8_Part_2-199710151-00064","volume":"127","author":"DB Rubin","year":"1997","unstructured":"Rubin DB (1997) Estimating causal effects from large data sets using propensity scores. Ann Intern Med 127:757\u2013763","journal-title":"Ann Intern Med"},{"issue":"3","key":"2318_CR25","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1080\/10618600.1996.10474713","volume":"5","author":"R Ihaka","year":"1996","unstructured":"Ihaka R, Gentleman R (1996) R: a language for data analysis and graphics. J Comput Graph Stat 5(3):299\u2013314","journal-title":"J Comput Graph Stat"},{"issue":"22","key":"2318_CR26","doi-asserted-by":"crossref","first-page":"3591","DOI":"10.1200\/JCO.2010.28.0784","volume":"28","author":"JC Boughey","year":"2010","unstructured":"Boughey JC, Hartmann LC, Anderson SS et al (2010) Evaluation of the Tyrer\u2013Cuzick (International Breast Cancer Intervention Study) model for breast cancer risk prediction in women with atypical hyperplasia. J Clin Oncol 28(22):3591\u20133596","journal-title":"J Clin Oncol"},{"issue":"6","key":"2318_CR27","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1002\/cncr.22113","volume":"107","author":"BK McLaren","year":"2006","unstructured":"McLaren BK, Schuyler PA, Sanders ME et al (2006) Excellent survival, cancer type, and Nottingham grade after atypical lobular hyperplasia on initial breast biopsy. Cancer 107(6):1227\u20131233","journal-title":"Cancer"},{"issue":"24","key":"2318_CR28","doi-asserted-by":"crossref","first-page":"5534","DOI":"10.1200\/JCO.2005.04.038","volume":"23","author":"PJ Chuba","year":"2005","unstructured":"Chuba PJ, Hamre MR, Yap J et al (2005) Bilateral risk for subsequent breast cancer after lobular carcinoma-in situ: analysis of surveillance, epidemiology, and end results data. J Clin Oncol 23(24):5534\u20135541","journal-title":"J Clin Oncol"},{"key":"2318_CR29","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/S1470-2045(11)70030-4","volume":"12","author":"J Cuzick","year":"2011","unstructured":"Cuzick J, DeCensi A, Arun B et al (2011) Preventive therapy for breast cancer: a consensus statement. Lancet Oncol 12:496\u2013503","journal-title":"Lancet Oncol"},{"key":"2318_CR30","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s10549-009-0618-4","volume":"119","author":"A Fagerlin","year":"2010","unstructured":"Fagerlin A, Zikmund-Fisher BJ, Smith DM et al (2010) Women\u2019s decisions regarding tamoxifen for breast cancer prevention: responses to a tailored decision aid. Breast Cancer Res Treat 119:613\u2013620","journal-title":"Breast Cancer Res Treat"},{"issue":"33","key":"2318_CR31","doi-asserted-by":"crossref","first-page":"5374","DOI":"10.1200\/JCO.2007.14.8833","volume":"26","author":"VS Pankratz","year":"2008","unstructured":"Pankratz VS, Hartmann LC, Degnim AC et al (2008) Assessment of the accuracy of the gail model in women with atypical hyperplasia. J Clin Oncol 26(33):5374\u20135379","journal-title":"J Clin Oncol"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-012-2318-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-012-2318-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-012-2318-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T19:18:43Z","timestamp":1714504723000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-012-2318-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11,2]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["2318"],"URL":"https:\/\/doi.org\/10.1007\/s10549-012-2318-8","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,11,2]]}}}